EE554 Costs Comparison Between Dupilumab and Omalizumab in the Treatment of Severe Allergic Asthma in the Brazilian Private Healthcare Perspective
| Autor: | Barbosa, A, Magro, FJB, Taminato, A, Federico, P, Prioli, RNT, Goldflus, S, Migliavaca, CB, Falavigna, M |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S164-S164 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect